Agios Pharmaceuticals Inc., of Cambridge, Mass., appointed Bruce Car chief scientific officer, effective Jan. 6, 2020.
Hemostemix Inc., of Calgary, Alberta, appointed Thomas Smeenk to its board.
Intercept Pharmaceuticals Inc., of New York, appointed Jason Campagna chief medical officer.
Orexo AB, of Uppsala, Sweden, appointed Dennis Urbaniak executive vice president of digital health.
Poxel SA, of Lyon, France, appointed Quentin Durand chief legal officer.
Xenikos B.V., of Nijmegen, the Netherlands, appointed Stanley Musial chief financial officer and chief business officer.